Recently diagnosed with HIV? Click here

What is ‘best practice’ if I have hepatitis C as well as HIV?

From Treat Yourself Right • 2 July 2009

What is ‘best practice’ if I have hepatitis C as well as HIV?

Treating your HIV with combination ARVA medication or other substance which is active against retroviruses such as HIV. is definitely recommended if you have hepatitis C (HCVHepatitis C virus.), as HIV replication makes it more likely that you could transmit (HCV) to your baby.

Treating your HIV lessens the chance of HCV transmission (otherwise the chance of HCV transmission is estimated as up to 18%). The goal of therapy would be to keep HIV viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. below 50 copies/ml if possible.

However, do not treat your HCV during, or up to six months before pregnancy. One of the drugs used to treat HCV, ribavirinAn antiviral drug which is effective against a range of viruses including herpes, the hepatitis C virus and several strains of influenza. , is associated with birth defects and foetal death. Pregnancy does not affect HCV progression unless you have cirrhosis (scarring of the liverA large organ, located in the upper right abdomen, which assists in digestion by metabolising carbohydrates, fats and proteins, stores vitamins and minerals, produces amino acids, bile and cholesterol, and removes toxins from the blood.).

During pregnancy, avoid invasive procedures like amniocentesis because this procedure could enable infection of your baby to occur.

Risk of HCV transmission is increased during delivery if your waters break more than six hours before delivery (‘prolonged rupture of membranes’, which also increases the chance of HIV transmission). For this reason having a pre-labour elective caesarean is often recommended, although there is no research actually showing that this decreases transmission (the studies have not been done). Any invasive monitoring procedures such as foetal scalp monitoring are also advised against.

Infant HCV

Hepatitis C antibodies will pass from the mother to the baby. These antibodies don’t clear from your child’s system until about 18 months of age. He or she can be tested for hepatitis C at that time, but if it is important to know before that time; a hepatitis C PCR test can be carried out at 1-2 months, and then repeated. If both of these are negative, your child does not have hepatitis C infection, even though antibodies will remain for some time.

If your child does have HCV don’t be alarmed. Children are usually symptom free, and they have a better response to HCV treatment than adults, often experiencing few or no side effects.

Disease progression is usually minimal for the first 20 years. Children cannot undergo treatment for HCV until they are 18 years old.

Treat Yourself Right

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

The article you are viewing is part of the larger (multi-page) resource Treat Yourself Right.

View the introductory page.

In stock. Printed copies of this resource are available from the NAPWA office. Contact NAPWA if you would like a copy mailed to you.

This Resource was first published on 2 July 2009 — more than two years ago.

While the content of this resource was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

This article may contain medical information. NAPWA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.

The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.